Call Today
1-866-735-2792
Web Resources & Medical News
Anapol Schwartz Attorney Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation. More>>
Worldwide Aprotin Doubles the Risk of Kidney Failure
A drug approved by the FDA, and sold worldwide for the last 13 years has now been proven to double a patient's risk of kidney failure, and increase the risk of heart attack, heart failure, and stroke. The drug Aprotinin has been given to an estimated one million surgery patients to limit bleeding. The maker of Aprontin (Bayer AG) tried to cover up the study and proceed with business as usual – putting patients’ lives at risk. More>>
Do You Have a Aprotinin Lawsuit? »
Aprotinin: New England Journal of Medicine Study
The results, published in this week's New England Journal of Medicine, are based on an independent, non-commercial, observational study conducted by The Ischemia Research and Education Foundation (IREF). More>>
FDA Approves Aprotinin (1993)
1993-The Food and Drug Administration today announced approval of aprotinin, a drug that can reduce the need for blood transfusions in patients undergoing heart bypass surgery. Its use should be reserved for high risk patients, however, because severe allergic reactions can result from using it more than once in a patient. Kidney toxicity was also a problem in some patients in the trials. At that time there were problems noted. More>>
Official Trasylol Website by Bayer
This information is mainly directed to the healthcare professional and omits the new knowledge released about how it doubles the risk of kidney failure. More>>
Aprotinin Drug Analysis
Anaphylactic reactions are possible when Trasylol is administered. Anaphylaxis may occur after ingestion, inhalation, skin contact, or injection of an allergen. The most severe type of anaphylaxis-anaphylactic shock-will usually lead to death in minutes if left untreated. More>>
Contact Our Trasylol Lawyers Today »
Other Links:
Clotting Drug Trasylol/aprontin Increases Kidney Dialysis Risk
Bayer Purposely Fails to Disclose Aprotinin Trasylol Dangers
Frequently Asked Questions about Aprotinin/Trasylol
Trasylol Wrongful Death Complaint
